Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2024
DOI: 10.1089/mab.2024.0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2024. Verfasst von Rena Ubukata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Receptors, CCR5, Cricetulus, Antibodies, Monoclonal, Immunization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
One of the G protein-coupled receptors, C-C chemokine receptor 5 (CCR5), is an important regulator for the activation of T and B lymphocytes, dendritic cells, natural killer cells, and macrophages. Upon binding to its ligands, CCR5 activates downstream signaling, which is an important regulator in the innate and adaptive immune response through the promotion of lymphocyte migration and the secretion of proinflammatory cytokines. Anti-CCR5 monoclonal antibodies (mAbs) have been developed and evaluated in clinical trials for tumors and inflammatory diseases. In this study, we developed novel mAbs for mouse CCR5 (mCCR5) using the N-terminal peptide immunization. Among the established anti-mCCR5 mAbs, C 5 Mab-4 (rat IgG 2a , kappa) and C 5 Mab-8 (rat IgG 1 , kappa), recognized mCCR5-overexpressing Chinese hamster ovary-K1 (CHO/mCCR5) and an endogenously mCCR5-expressing cell line (L1210) by flow cytometry. The dissociation constant ( K D ) values of C 5 Mab-4 and C 5 Mab-8 for CHO/mCCR5 were determined as 3.5 × 10 −8 M and 7.3 × 10 −9 M, respectively. Furthermore, both C 5 Mab-4 and C 5 Mab-8 could detect mCCR5 by western blotting. These results indicated that C 5 Mab-4 and C 5 Mab-8 are useful for detecting mCCR5 by flow cytometry and western blotting and provide a possibility to obtain the proof of concept in preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Yukinari Kato
Zitieren
APA
Ubukata, R., Suzuki, H., Tanaka, T., Li, G., Kaneko, M. K., & Kato, Y. (2024). Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2024.0009
Vancouver
Ubukata R, Suzuki H, Tanaka T, Li G, Kaneko MK, Kato Y. Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2024. doi:10.1089/mab.2024.0009
BibTeX
@article{Ubukata2024,
author = {Ubukata, Rena and Suzuki, Hiroyuki and Tanaka, Tomohiro and Li, Guanjie and Kaneko, Mika K and Kato, Yukinari},
title = {Development of Sensitive Anti-Mouse CCR5 Monoclonal Antibodies Using the N-Terminal Peptide Immunization},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2024},
doi = {10.1089/mab.2024.0009}
}
EUVIMED